Detalhe da pesquisa
1.
Five-year follow-up of KEYNOTE-087: pembrolizumab monotherapy for relapsed/refractory classical Hodgkin lymphoma.
Blood
; 142(10): 878-886, 2023 09 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37319435
2.
Pembrolizumab in relapsed or refractory primary mediastinal large B-cell lymphoma: final analysis of KEYNOTE-170.
Blood
; 142(2): 141-145, 2023 07 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-37130017
3.
Real-world patient characteristics, treatment patterns, and treatment outcomes of patients with diffuse large B-cell lymphoma by line of therapy.
Cancer Med
; 13(7): e7173, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38597118
4.
Adenoid cystic carcinoma: A review of recent advances, molecular targets, and clinical trials.
Head Neck
; 38(4): 620-7, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25487882
5.
Accelerated fraction radiotherapy with capecitabine as neoadjuvant therapy for borderline resectable pancreatic cancer.
Gastrointest Cancer Res
; 7(1): 15-22, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-24558510
6.
Endometrial hormone receptors in women with dysfunctional uterine bleeding.
Arch Gynecol Obstet
; 272(1): 17-22, 2005 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-15300446